JP2021509912A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021509912A5 JP2021509912A5 JP2020547357A JP2020547357A JP2021509912A5 JP 2021509912 A5 JP2021509912 A5 JP 2021509912A5 JP 2020547357 A JP2020547357 A JP 2020547357A JP 2020547357 A JP2020547357 A JP 2020547357A JP 2021509912 A5 JP2021509912 A5 JP 2021509912A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- composition according
- vegf antagonist
- vegf
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021142541A JP2021191778A (ja) | 2018-03-16 | 2021-09-01 | 眼疾患を治療するための方法 |
| JP2023212445A JP2024042697A (ja) | 2018-03-16 | 2023-12-15 | 眼疾患を治療するための方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862643887P | 2018-03-16 | 2018-03-16 | |
| US62/643,887 | 2018-03-16 | ||
| US201962805344P | 2019-02-14 | 2019-02-14 | |
| US62/805,344 | 2019-02-14 | ||
| PCT/IB2019/051899 WO2019175727A1 (en) | 2018-03-16 | 2019-03-08 | Methods for treating ocular diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021142541A Division JP2021191778A (ja) | 2018-03-16 | 2021-09-01 | 眼疾患を治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021509912A JP2021509912A (ja) | 2021-04-08 |
| JP2021509912A5 true JP2021509912A5 (https=) | 2021-05-20 |
| JP6938796B2 JP6938796B2 (ja) | 2021-09-22 |
Family
ID=66049363
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020547357A Active JP6938796B2 (ja) | 2018-03-16 | 2019-03-08 | 眼疾患を治療するための方法 |
| JP2021142541A Withdrawn JP2021191778A (ja) | 2018-03-16 | 2021-09-01 | 眼疾患を治療するための方法 |
| JP2023212445A Withdrawn JP2024042697A (ja) | 2018-03-16 | 2023-12-15 | 眼疾患を治療するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021142541A Withdrawn JP2021191778A (ja) | 2018-03-16 | 2021-09-01 | 眼疾患を治療するための方法 |
| JP2023212445A Withdrawn JP2024042697A (ja) | 2018-03-16 | 2023-12-15 | 眼疾患を治療するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210017266A1 (https=) |
| EP (1) | EP3765083A1 (https=) |
| JP (3) | JP6938796B2 (https=) |
| KR (2) | KR20200131839A (https=) |
| CN (1) | CN111867631A (https=) |
| AU (2) | AU2019235577B2 (https=) |
| CA (1) | CA3091096A1 (https=) |
| IL (2) | IL277333B2 (https=) |
| MX (1) | MX2020009140A (https=) |
| TW (1) | TWI727279B (https=) |
| WO (1) | WO2019175727A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2494108C2 (ru) | 2006-04-07 | 2013-09-27 | Аерпио Терапетикс, Инк. | Антитела, которые связывают человеческий белок бета-тирозин фосфатазу (нртрвета), и их использование |
| KR102050040B1 (ko) | 2008-06-25 | 2019-11-28 | 에스바테크 - 어 노바티스 컴파니 엘엘씨 | ＴＮＦα를 저해하는 안정한 가용성 항체 |
| BRPI0914251B1 (pt) | 2008-06-25 | 2022-07-19 | Novartis Ag | Imunoligante recombinante, seu fragmento de ligação ao antígeno, uso dos mesmos, e composição |
| PL2307458T3 (pl) | 2008-06-25 | 2018-08-31 | Esbatech, An Alcon Biomedical Research Unit Llc | Humanizacja przeciwciał króliczych z zastosowaniem uniwersalnego zrębu przeciwciała |
| WO2013056240A1 (en) | 2011-10-13 | 2013-04-18 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome and cancer |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| TWI806150B (zh) | 2014-11-07 | 2023-06-21 | 瑞士商諾華公司 | 穩定的含有高濃度抗vegf抗體之蛋白質溶液調配物 |
| WO2017093969A1 (en) | 2015-12-04 | 2017-06-08 | Novartis Ag | Compositions and methods for immunooncology |
| KR20250057128A (ko) | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| WO2018175636A2 (en) | 2017-03-22 | 2018-09-27 | Novartis Ag | Compositions and methods for immunooncology |
| EP3758737A4 (en) | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| KR20200131839A (ko) * | 2018-03-16 | 2020-11-24 | 노파르티스 아게 | 안질환의 치료 방법 |
| WO2020068653A1 (en) | 2018-09-24 | 2020-04-02 | Aerpio Pharmaceuticals, Inc. | MULTISPECIFIC ANTIBODIES THAT TARGET HPTP - β (VE-PTP) AND VEGF |
| PE20211602A1 (es) | 2018-12-18 | 2021-08-18 | Novartis Ag | Formulacion de solucion de proteinas que contiene una alta concentracion de un anticuerpo anti-vegf |
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| PT3884929T (pt) | 2020-03-25 | 2023-08-09 | Ocular Therapeutix Inc | Implante ocular contendo um inibidor da tirosina cinase |
| CN116195003A (zh) * | 2020-09-23 | 2023-05-30 | 基因泰克公司 | 对黄斑水肿患者的注射频率的机器学习预测 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| PE20260040A1 (es) | 2023-04-11 | 2026-01-09 | Ocular Therapeutix Inc | Implante ocular que contiene un inhibidor de la tirosina cinasa |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1802334E (pt) | 2004-10-21 | 2012-11-28 | Genentech Inc | Método para tratamento de doenças neovasculares intraoculares |
| BRPI0914251B1 (pt) | 2008-06-25 | 2022-07-19 | Novartis Ag | Imunoligante recombinante, seu fragmento de ligação ao antígeno, uso dos mesmos, e composição |
| KR20190049934A (ko) * | 2011-01-13 | 2019-05-09 | 리제너론 파아마슈티컬스, 인크. | 혈관신생 눈 장애를 치료하기 위한 vegf 길항제의 용도 |
| EP2890389A1 (en) * | 2012-08-28 | 2015-07-08 | Novartis AG | Use of a vegf antagonist in treating ocular vascular proliferative diseases |
| TWI806150B (zh) * | 2014-11-07 | 2023-06-21 | 瑞士商諾華公司 | 穩定的含有高濃度抗vegf抗體之蛋白質溶液調配物 |
| PE20181363A1 (es) * | 2015-09-23 | 2018-08-27 | Genentech Inc | Variantes optimizadas de anticuerpos anti-vegf |
| KR20200131839A (ko) * | 2018-03-16 | 2020-11-24 | 노파르티스 아게 | 안질환의 치료 방법 |
-
2019
- 2019-03-08 KR KR1020207028377A patent/KR20200131839A/ko not_active Ceased
- 2019-03-08 AU AU2019235577A patent/AU2019235577B2/en active Active
- 2019-03-08 CA CA3091096A patent/CA3091096A1/en active Pending
- 2019-03-08 JP JP2020547357A patent/JP6938796B2/ja active Active
- 2019-03-08 MX MX2020009140A patent/MX2020009140A/es unknown
- 2019-03-08 IL IL277333A patent/IL277333B2/en unknown
- 2019-03-08 KR KR1020267006178A patent/KR20260036043A/ko active Pending
- 2019-03-08 EP EP19715998.1A patent/EP3765083A1/en active Pending
- 2019-03-08 CN CN201980017221.0A patent/CN111867631A/zh active Pending
- 2019-03-08 US US16/980,679 patent/US20210017266A1/en active Pending
- 2019-03-08 WO PCT/IB2019/051899 patent/WO2019175727A1/en not_active Ceased
- 2019-03-14 TW TW108108562A patent/TWI727279B/zh active
-
2021
- 2021-09-01 JP JP2021142541A patent/JP2021191778A/ja not_active Withdrawn
- 2021-12-14 AU AU2021286278A patent/AU2021286278C1/en active Active
-
2023
- 2023-12-15 JP JP2023212445A patent/JP2024042697A/ja not_active Withdrawn
-
2025
- 2025-10-09 IL IL323849A patent/IL323849A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021509912A5 (https=) | ||
| JP2018100276A5 (https=) | ||
| EP3817722A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM | |
| JP2016028092A5 (https=) | ||
| JP2019142968A5 (https=) | ||
| JP2016065085A5 (https=) | ||
| JP2018012698A5 (https=) | ||
| JP2015125255A5 (https=) | ||
| JP2015078230A5 (https=) | ||
| JP2015528502A5 (https=) | ||
| JP2018064407A5 (https=) | ||
| JP2017537928A5 (https=) | ||
| JP2016540026A5 (https=) | ||
| JP2020528637A5 (https=) | ||
| JP2016535100A5 (https=) | ||
| JP2016540019A5 (https=) | ||
| JP2020504434A5 (https=) | ||
| JP2015518492A5 (https=) | ||
| JP2020054657A5 (https=) | ||
| JP2022544380A5 (https=) | ||
| JP2017531686A5 (https=) | ||
| JP2021129286A5 (https=) | ||
| JP2020536085A5 (https=) | ||
| MX2020005483A (es) | Antagonistas de ildr2 y combinaciones de los mismos. | |
| EP3914234A4 (en) | Pharmaceutical compositions |